 | |
| BC Idonwanna sez: Inject bleach under UV lamp, too. I call medicine man! credit: N. Beeler |
A scientist who worked on the US government's response to the HIV epidemic said remdesivir is far from a miracle cure. “Remdesivir doesn’t work at all, as far as I can tell, or has only a minor effect,” according to William Haseltine. Haseltine compared remdesivir to tamiflu, which has been available by prescription for twenty years. Haseltine founded the departments of biochemical pharmacology and human retrovirology at Harvard. A Chinese study of the drug published in the Lancet, showed that the drug did not have any anti-viral effect. “That’s why I call it the fuzzy-wuzzy drug,” Haseltine added. What the drug does do, based on results of a study conducted by the National Institutes of Allergies and Infectious Disease, is shorten by 11 days the recovery time in patients suffering from COVID-19. It did not reduce the risk of death, or help severely ill patients on respirators.
Once more, a combination of other drugs appears to be more effective than Remdesivir. Patients who took interferon beta-1b, lopinavir-ritonavir, and ribavirin got better in seven days as opposed to 12 days for those who didn’t take it. The combination also has a measurable anti-viral effect that Remdesivir does not have, according to a study published in the Lancet on May 8th. No one is standing line for this treatment for good reason. Gillead stands to earn millions for years to come off of Remdesivir, so it is carefully orchestrating its rollout, dolling out minute amounts of samples, dripping tailored press teasers, and highlighting its compassionate use program. Gillead has been criticized before for its drug sales promotion, particularly for the exorbitant pricing of its HIV medicine Truvada and hepatitis C drug sofosbuvir, which sells for $1,000 a pill. Remdesivir received emergency use authorization from the FDA on May 1st, despite an indication that the new drug could have adverse side effects on the kidney and liver. More research on this issue was called off by the NIAID. The current climate of power politics and unrestrained greed in a time of plague is distorting the regulation of new drug and vaccine treatments to the detriment of the public they are supposed to be helping.
 |
| Dow 25,000: It's how they do... |
{26.05.20} After the Lancet study was released showing no beneficial effects from COVID-19 treatment with hydroxychloroquine and increased risk of death, France moved to ban use of the chemical except in clinical trials. Shortly after that announcement, the country's drug regulator banned its use in clinical trials WHO announced Monday that it was suspending clinical trials of the drug. If the mendacious Total Douche was taking the drug--US Person thinks that claim like many he makes is open to doubt--he increased his risk of heart dysfunction. He is already in a high mortality category (obesity) if he contracts COVID-19, Perhaps fear of death motivated him to to self-administer a potentially dangerous prophylactic. Awesome dude? Not so much.
Meanwhile® the former state epidemiologist for Sweden cast doubt on her country's decision not to impose a mass quarantine. Sweden is now experiencing one of the highest mortality rates in the world reports AP. Annika Linde told AP that in retrospect an early lockdown could have saved lives. Linde was Sweden's Dr. Fauci from 2005 to 2013 and led the country's response to swine flu and SARS. Her criticism of the country's relatively lax strategy for combating SARS CoV-2 virus was prompted by a current health minister claiming Sweden's strategy was "the best in the wolrd". Linde said, “I felt this can’t go on. Such a denial may prevent us from acting rationally.” Ditto, Dr. Linde.
{23.05.20}Another study, published in the respected English medical journal, Lancet, explodes the myth of hydroxychloroquinine as a treatment for COVID-19, finding no beneficial effects, and a link to increased rates of mortality and heart rhythm complications in 96,000 hospital patients. The Veterans Affairs department revealed that it has administered the anti-malaria drug to 1,300 veterans suffering virus infections at VA medical centers without a discernible beneficial effect. When asked why it was using the untested drug to treat COVID-19 by Senator Schumer, the agency responded it was doing so in accordance with FDA guidelines permitting experimental use, and because veteran families were requesting the treatment.
Obese, older patients such as Total Douche (240-280lbs; BMI 30.4) are in a high risk mortality category if they contract COVID-19. Someone should check his bloodlines before its too late.
US Death Toll (est.): 133,800.
credit: Tom Toles, Washington Post
 |
| What is the truth?... |